P2X receptors and diabetes

Carmen Fotino, Andrea Vergani, Paolo Fiorina, Antonello Pileggi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Diabetes is a metabolic disorder characterized by elevation of glucose levels in the blood that develops in humans as a result of genetic predisposition and environmental factors. Unbalanced glycemic control has been associated with the development of progressive and debilitating complications that dramatically affect the quality of life and life expectancy of people with diabetes. The purinergic system represents a widely diffused signaling pathway in mammalian cells of different tissues where it plays critical roles in both physiological and pathological conditions. Herein we review the increasing evidence supporting that the purinergic system plays an important role in the multiple facets of diabetes, including its physiopathology and complications. We also discuss the potential relevance of the purinergic pathway for diagnosis and treatment of diabetes.

Original languageEnglish (US)
Pages (from-to)891-901
Number of pages11
JournalCurrent Medicinal Chemistry
Volume22
Issue number7
StatePublished - 2015
Externally publishedYes

Fingerprint

Genetic Predisposition to Disease
Medical problems
Life Expectancy
Quality of Life
Glucose
Blood
Cells
Tissue

Keywords

  • Beta cell
  • Diabetes
  • Extracellular ATP
  • Inflammation
  • Islet immunity
  • Islets
  • Metabolic syndrome
  • P2X
  • Purinergic receptors
  • Type 1 diabetes
  • Type 2 diabetes

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Fotino, C., Vergani, A., Fiorina, P., & Pileggi, A. (2015). P2X receptors and diabetes. Current Medicinal Chemistry, 22(7), 891-901.

P2X receptors and diabetes. / Fotino, Carmen; Vergani, Andrea; Fiorina, Paolo; Pileggi, Antonello.

In: Current Medicinal Chemistry, Vol. 22, No. 7, 2015, p. 891-901.

Research output: Contribution to journalArticle

Fotino, C, Vergani, A, Fiorina, P & Pileggi, A 2015, 'P2X receptors and diabetes', Current Medicinal Chemistry, vol. 22, no. 7, pp. 891-901.
Fotino C, Vergani A, Fiorina P, Pileggi A. P2X receptors and diabetes. Current Medicinal Chemistry. 2015;22(7):891-901.
Fotino, Carmen ; Vergani, Andrea ; Fiorina, Paolo ; Pileggi, Antonello. / P2X receptors and diabetes. In: Current Medicinal Chemistry. 2015 ; Vol. 22, No. 7. pp. 891-901.
@article{54d8dc2d3cb349e8b4ebbfe90707ed14,
title = "P2X receptors and diabetes",
abstract = "Diabetes is a metabolic disorder characterized by elevation of glucose levels in the blood that develops in humans as a result of genetic predisposition and environmental factors. Unbalanced glycemic control has been associated with the development of progressive and debilitating complications that dramatically affect the quality of life and life expectancy of people with diabetes. The purinergic system represents a widely diffused signaling pathway in mammalian cells of different tissues where it plays critical roles in both physiological and pathological conditions. Herein we review the increasing evidence supporting that the purinergic system plays an important role in the multiple facets of diabetes, including its physiopathology and complications. We also discuss the potential relevance of the purinergic pathway for diagnosis and treatment of diabetes.",
keywords = "Beta cell, Diabetes, Extracellular ATP, Inflammation, Islet immunity, Islets, Metabolic syndrome, P2X, Purinergic receptors, Type 1 diabetes, Type 2 diabetes",
author = "Carmen Fotino and Andrea Vergani and Paolo Fiorina and Antonello Pileggi",
year = "2015",
language = "English (US)",
volume = "22",
pages = "891--901",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "7",

}

TY - JOUR

T1 - P2X receptors and diabetes

AU - Fotino, Carmen

AU - Vergani, Andrea

AU - Fiorina, Paolo

AU - Pileggi, Antonello

PY - 2015

Y1 - 2015

N2 - Diabetes is a metabolic disorder characterized by elevation of glucose levels in the blood that develops in humans as a result of genetic predisposition and environmental factors. Unbalanced glycemic control has been associated with the development of progressive and debilitating complications that dramatically affect the quality of life and life expectancy of people with diabetes. The purinergic system represents a widely diffused signaling pathway in mammalian cells of different tissues where it plays critical roles in both physiological and pathological conditions. Herein we review the increasing evidence supporting that the purinergic system plays an important role in the multiple facets of diabetes, including its physiopathology and complications. We also discuss the potential relevance of the purinergic pathway for diagnosis and treatment of diabetes.

AB - Diabetes is a metabolic disorder characterized by elevation of glucose levels in the blood that develops in humans as a result of genetic predisposition and environmental factors. Unbalanced glycemic control has been associated with the development of progressive and debilitating complications that dramatically affect the quality of life and life expectancy of people with diabetes. The purinergic system represents a widely diffused signaling pathway in mammalian cells of different tissues where it plays critical roles in both physiological and pathological conditions. Herein we review the increasing evidence supporting that the purinergic system plays an important role in the multiple facets of diabetes, including its physiopathology and complications. We also discuss the potential relevance of the purinergic pathway for diagnosis and treatment of diabetes.

KW - Beta cell

KW - Diabetes

KW - Extracellular ATP

KW - Inflammation

KW - Islet immunity

KW - Islets

KW - Metabolic syndrome

KW - P2X

KW - Purinergic receptors

KW - Type 1 diabetes

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84926486401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926486401&partnerID=8YFLogxK

M3 - Article

C2 - 25312216

AN - SCOPUS:84926486401

VL - 22

SP - 891

EP - 901

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 7

ER -